Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1985Cancer

High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

DADavid J. AdelsteinCleveland ClinicHLHillard M. LazarusNorthwestern UniversityJHJohn HinesJohnson & Johnson (United Kingdom)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Adelstein et al. (1985) studied this question.

synapsesocial.com/papers/6a7d323ac7e6f6a50737d09dhttps://doi.org/10.1002/1097-0142(19851001)56:7<1493::aid-cncr2820560702>3.0.co;2-m
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-dose cytosine arabinoside in non-Hodgkin's lymphoma.1983 · 77 citations
  2. 2Cyclophosphamide, Vincristine, Methotrexate with Leucovorin Rescue, and Cytarabine (COMLA) Combination Sequential Chemotherapy for Advanced Diffuse Histiocytic Lymphoma1980 · 159 citations
  3. 3High dose cytosine arabinoside (HDARAC) in refractory acute leukemia1979 · 287 citations
  4. 4High Dose Cytosine Arabinoside in the Management of Refractory Acute Leukaemia1982 · 88 citations
  5. 5The Clinical Pharmacology of Antineoplastic Agents1975 · 123 citations